Hundreds of Americans are suing GLP-1 drug makers after experiencing vision loss, including a Georgia nurse who lost sight in one eye while taking Wegovy. Patients report they were not adequately warned about the rare eye condition NAION, though drug companies dispute the link and claim labels contain appropriate warnings.